Shanghai Aohua Photoelectricity Endoscope Co Ltd
SSE:688212
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/S
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Valuation Scenarios
If P/S returns to its 3-Year Average (9.9), the stock would be worth ¥49.32 (41% upside from current price).
| Scenario | P/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 7 | ¥34.96 |
0%
|
| 3-Year Average | 9.9 | ¥49.32 |
+41%
|
| 5-Year Average | 10.6 | ¥52.8 |
+51%
|
| Industry Average | 4.4 | ¥21.89 |
-37%
|
| Country Average | 2.8 | ¥13.75 |
-61%
|
Forward P/S
Today’s price vs future revenue
| Today's Market Cap | Revenue | Forward P/S | ||
|---|---|---|---|---|
|
¥5.7B
|
/ |
Oct 2025
¥671.6m
|
= |
|
|
¥5.7B
|
/ |
Dec 2025
¥754.9m
|
= |
|
|
¥5.7B
|
/ |
Dec 2026
¥914.3m
|
= |
|
|
¥5.7B
|
/ |
Dec 2027
¥1.1B
|
= |
|
|
¥5.7B
|
/ |
Dec 2028
¥1.8B
|
= |
|
|
¥5.7B
|
/ |
Dec 2029
¥1.8B
|
= |
|
|
¥5.7B
|
/ |
Dec 2030
¥2.2B
|
= |
|
|
¥5.7B
|
/ |
Dec 2031
¥2.6B
|
= |
|
|
¥5.7B
|
/ |
Dec 2032
¥3B
|
= |
|
|
¥5.7B
|
/ |
Dec 2033
¥3.5B
|
= |
|
Forward P/S shows whether today’s P/S still looks high or low once future revenue are taken into account.
Peer Comparison
| Market Cap | P/S | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
S
|
Shanghai Aohua Photoelectricity Endoscope Co Ltd
SSE:688212
|
4.7B CNY | 7 | -65.2 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
162.5B USD | 16.2 | 57.1 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
157.7B USD | 3.4 | 24.8 | |
| US |
|
Stryker Corp
NYSE:SYK
|
120.5B USD | 4.6 | 35.7 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
103.9B USD | 2.9 | 22.3 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
85.4B USD | 4.2 | 24 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.5B USD | 7.6 | 44 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
39.3B EUR | 1.7 | 18.6 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
44.7B USD | 10.5 | 42.7 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
42.4B USD | 1.9 | 24 | |
| US |
|
Resmed Inc
NYSE:RMD
|
31.1B USD | 5.5 | 20 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.5 |
| Median | 2.8 |
| 70th Percentile | 5.4 |
| Max | 5 034 353.9 |
Other Multiples
Shanghai Aohua Photoelectricity Endoscope Co Ltd
Glance View
Shanghai Aohua Photoelectricity Endoscope Co., Ltd. engages in the research, development, production, and sale of endoscope products. The company is headquartered in Shanghai, Shanghai and currently employs 865 full-time employees. The company went IPO on 2021-11-15. The firm's main businesses are the research, development, production and sales of electronic endoscopic equipment and endoscopic diagnostic and surgical consumables. The firm's products include endoscopic equipment and endoscopic diagnostic and surgical consumables. The firm's products are mainly used in clinical departments such as gastroenterology, respiratory, ears, nose, and throat (ENT), gynecology, and emergency departments.
